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Insertion sequences drive the emergence of a highly adapted
human pathogen
Erwin Sentausa,1† Pauline Basso,1‡ Alice Berry,1 Annie Adrait,2 Gwendoline Bellement,1,2§ Yohann Coute,2
Stephen Lory,3 Sylvie Elsen1,* and Ina Attree1,*
Abstract
Pseudomonas aeruginosa is a highly adaptive opportunistic pathogen that can have serious health consequences in patients
with lung disorders. Taxonomic outliers of P. aeruginosa of environmental origin have recently emerged as infectious for
humans. Here, we present the first genome-wide analysis of an isolate that caused fatal haemorrhagic pneumonia. In two
clones, CLJ1 and CLJ3, sequentially recovered from a patient with chronic pulmonary disease, insertion of a mobile genetic
element into the P. aeruginosa chromosome affected major virulence-associated phenotypes and led to increased resistance
to the antibiotics used to combat the infection. Comparative genome, proteome and transcriptome analyses revealed that this
ISL3-family insertion sequence disrupted the genes for flagellar components, type IV pili, O-specific antigens, translesion
polymerase and enzymes producing hydrogen cyanide. Seven-fold more insertions were detected in the later isolate, CLJ3,
than in CLJ1, some of which modified strain susceptibility to antibiotics by disrupting the genes for the outer-membrane
porin OprD and the regulator of b-lactamase expression AmpD. In the Galleria mellonella larvae model, the two strains
displayed different levels of virulence, with CLJ1 being highly pathogenic. This study revealed insertion sequences to be
major players in enhancing the pathogenic potential of a P. aeruginosa taxonomic outlier by modulating both its virulence and
its resistance to antimicrobials, and explains how this bacterium adapts from the environment to a human host.
DATA SUMMARY
All data are available. The whole-genome shotgun projects
for CLJ1 and CLJ3 have been deposited at DDBJ/ENA/Gen-
Bank under accession numbers PVXJ00000000 and
PZJI00000000, respectively. The raw sequencing data were
deposited at NCBI’s Sequence Read Archive under acces-
sion numbers SRP170343 and SRP170410. The RNA-Seq
datasets have been uploaded to GEO under identifiers
GSE123106 and GSE123107. The MSy proteomics data
were deposited with the ProteomeXchange Consortium via
the PRIDE partner repository under dataset identifier
PXD011105. These data can be accessed on https://www.
ebi.ac.uk/pride/archive/. The RNA-Seq experiments were
performed in accordance with the ENCODE guidelines and
appropriately validated by RT-qPCR.
INTRODUCTION
Emerging infectious diseases caused by multidrug-resistant
bacteria represent a serious threat to human well-being and
health. Over the last 40 years, several hundred novel pathol-
ogies caused by infectious agents have been reported [1].
Environmental bacteria can adapt to a human host by
acquiring virulence traits through chromosomal rearrange-
ments due to the insertion of mobile genetic elements, hori-
zontal gene transfer or small local sequence changes, such
as single nucleotide substitutions [2, 3].
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The genus Pseudomonas is one of the largest groups of bac-
teria, found in diverse environments and capable of causing
both plant and animal diseases. Pseudomonas species such
as P. aeruginosa, P. fluorescens and P. syringae adversely
impact human health and agriculture [4–6]. P. aeruginosa is
a particularly successful opportunistic pathogen frequently
found in humid environments associated with human activ-
ities. In hospital settings, infections caused by multidrug-
resistant P. aeruginosa strains present a real danger for
elderly individuals, patients treated with immunosuppres-
sive therapies and users of invasive devices in intensive care
units. In addition to acute infections, P. aeruginosa is a com-
mon cause of chronic wound infections, and is linked to
long-lasting respiratory infections in patients with cystic
fibrosis (CF) and chronic obstructive pulmonary disease
(COPD). During chronic infections, the bacteria adjust to
their particular host environment by adapting their meta-
bolic pathways and synthesizing particular virulence-associ-
ated components [7]. Alterations occurring post-
colonization include acquisition of loss-of-function muta-
tions in genes of motility and antibiotic resistance, as well as
aggressive factors responsible for acute virulence [8–12].
Recent massive whole-genome sequencing has allowed
the classification of clinical and environmental P. aerugi-
nosa strains into four well-defined clades [13, 14]. The dif-
ferent clades rely on different toxins to exert their
pathogenic strategies. The two most populated clades inject
toxins, also referred to as effectors, ExoS, ExoT, ExoY and
ExoU, directly into the host cell cytoplasm using a type-III
secretion system (T3SS) [15]. The third and fourth clades
are occupied by strains lacking all the genes encoding the
effectors and the components of the T3SS. The first fully
sequenced taxonomic outlier, PA7, was found to be multi-
drug resistant and non-virulent in a mouse model of acute
lung infection [16, 17]. Other PA7-related strains were
mainly of environmental origin [18, 19], but were occasion-
ally associated with acute (wounds and urinary tract) and
chronic (CF and COPD) human infections [20–22]. Some
recently emerged highly virulent clones from those clades
secrete the pore-forming toxin Exolysin, ExlA, that was
found to be responsible for bacterial cytotoxicity [16, 21–
24]. The most pathogenic exlA+ P. aeruginosa strain
described to date is CLJ1, which was isolated at the Univer-
sity Hospital in Grenoble, France, from a COPD patient
with haemorrhagic pneumonia [16]. Experimentally
infected mice with CLJ1 had extensive damage to their lung
endothelial monolayers, and bacteria had transmigrated
into the blood and disseminated into secondary organs, all
without being detected by the host’s immune system. This
clinical scenario differs greatly from the consequences
observed with the T3SS+ strain PAO1 [16, 25].
To gain insight into the molecular determinants of patho-
genesis expressed by Exolysin-producing P. aeruginosa tax-
onomic outliers, and to assess the extent of evolutionary
adaptation during the course of infection, we performed a
comprehensive comparative genome-wide study of two
clonal variants, CLJ1 and CLJ3, isolated from the same
patient at different time-points during hospitalization. The
data gathered demonstrated that mobile genetic elements
belonging to the ISL3 insertion sequence (IS) family, origin-
ally found in soil bacteria P. stutzeri and P. putida, shaped
the virulence traits and strategies used by these strains to
colonize their human host, escape from the immune system
and resist antibiotic treatment.
METHODS
Bacterial strains and culture conditions
The P. aeruginosa strains used in this study were CLJ1 and
CLJ3 [16]. Bacteria were grown at 37

C in liquid Lysogeny
broth (LB) medium (per litre: 10 g Bacto tryptone, 5 g yeast
extract, 10 g NaCl) with shaking until the cultures reached
an optical density of 1.0 (or other value where indicated) at
600 nm (OD600). To assess levels of cyclic-di-GMP (c-di-
GMP), pUCP22-pcdrA-gfp(ASV)c was introduced into CLJ1
and CLJ3 strains by electroporation, as previously described
[26], and transformed bacteria were selected on LB agar
plates containing carbenicillin at 200 µgml 1.
Genome analysis
Details of sequencing, assembly, annotation and compari-
son can be found in the Supplementary Materials and Meth-
ods. The assembly and annotation statistics for the CLJ1
and CLJ3 genomes are presented in Table S1 (available in
the online version of this article). Functional annotation
was performed on the Rapid Annotations based on Subsys-
tem Technology (RAST) Genome Annotation Server, ver-
sion 2.0 [27], using the Classic RAST annotation scheme
and the GLIMMER-3 gene caller. Annotations were manu-
ally curated based on annotations of orthologous genes in
PA7 and PAO1 strains in the Pseudomonas Genome
IMPACT STATEMENT
Bacteria employ diverse strategies to adapt to changing
environments, including the infectious niche in human
hosts. Pseudomonas aeruginosa adapts to establish a
chronic infection in cystic fibrosis patients through small
nucleotide changes in pathoadaptive genes. In this study,
we demonstrate that P. aeruginosa clonal outliers use
another strategy to evade the host’s immune system and
to deal with the antibiotics used to treat the infection.
Using a genome-wide ‘multiomics’ approach, we discov-
ered that a single mobile genetic element belonging to
the ISL3 insertion sequence family altered (i) the struc-
ture of multiple surface macromolecules (flagella, pili,
lipopolysaccharide), (ii) the levels of proteins responsible
for antibiotic resistance, and (iii) the expression of some
virulence factors. Our work thus reveals another power-
ful means used by bacteria to rapidly adapt to a human
niche and deal with the threat posed by antimicrobials.
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Database [28]. Circos 0.69-3 [29] was used to create the
multiomic data visualizations for Figs 1 and S1.
Identifying insertion sites for IS elements
Locations of CLJ-ISL3 insertions in the gaps between CLJ3
contigs were detected by checking for the inverted repeat
sequences at contig ends, while taking the shared gene syn-
teny between CLJ1, PA7 and PAO1 genomes into account.
PanISa version 0.1.0 (https://github.com/bvalot/
panISa) [30] was also used, with default parameters, to
search for ISs in CLJ3 reads. Reads were mapped to the PA7
and CLJ1 genomes using the BWA-MEM algorithm from
BWA version 0.7.15 [31].
Transcriptome
The RNA for RNA-Seq was prepared as previously
described [32] from bacterial cultures grown in duplicate in
LB to an OD600 of 1. Briefly, total RNA was isolated using
the Direct-zol RNA MiniPrep kit (Zymo). Cells were col-
lected by centrifugation (8000 g, 5min) and the supernatant
was discarded. TRI Reagent (700 µl) was added to the pellet,
and bacteria were lysed by vigorous vortexing (2min). After
centrifugation at 13000 g for 1min, the lysate was trans-
ferred to a clean tube containing an equal volume of 100%
ethanol. The ethanol mixture was transferred to a Zymo-
Spin IIC Column placed in a collection tube and centri-
fuged. The column, to which RNAs were bound, was
washed according to the manufacturer’s protocol. RNA was
finally eluted with 40 µl nuclease-free water. rRNA was
depleted using the Ribo-Zero magnetic kit (Epicentre). The
Illumina libraries and sequencing were prepared according
to standard procedures at the Biopolymer Facility, Harvard
Medical School, Boston, USA. Data were analysed as
described in the Supplementary Materials and Methods.
The total number of reads mapped to the genes
was incorporated into a tabular format and analysed as raw
counts using the DESeq2 differential expression analysis
pipeline. Differentially expressed genes between CLJ1 and
CLJ3 were identified using a 5% false discovery rate (FDR).
MS-based quantitative proteomics analyses
Proteomics samples were prepared and analysed by nano-
LC coupled to tandem MS (Ultimate 3000 coupled to
an LTQ-Orbitrap Velos Pro; Thermo Scientific) as
described previously [33] with slight modifications (see
Supplementary Materials and Methods). Each fraction was
verified by western blot for purity using appropriate anti-
bodies. The protein content in the whole-cell, membrane
and secretome fractions of CLJ1 and CLJ3 was analysed
independently. Statistical analyses were performed using
ProStaR [34]. In total, a list of 2852 quantified proteins was
obtained. The MS proteomics data were deposited with the
ProteomeXchange Consortium via the PRIDE [35] partner
repository under dataset identifier PXD011105.
Phenotypic analyses
HCN production was assessed on induction plates contain-
ing arginine (an HCN precursor), as previously described
[22]. Briefly, a sheet impregnated with a Cu2+-containing
reaction mixture was placed above agar plates seeded with
bacteria. A white-to-blue colour transition indicates HCN
production. The fluorescence-based reporter plasmid
pUCP22-pCdrA-gfp(ASV)c was used to monitor levels of c-
di-GMP [36]. Bacteria carrying the plasmid were subcul-
tured to an OD600 of 0.05 in a black 96-well plate with a
clear bottom, and incubated at 37

C under 60 r.p.m. in the
Fluoroskan reader. Fluorescence was measured every
15min for 6 h, and emission was monitored at 527 nm fol-
lowing excitation at 485 nm. Serum sensitivity was assessed
by a protocol adapted from the literature [37]. Two different
human sera provided by the French National blood service
(EFS) were used in all experiments. Overnight cultures of
CLJ1 and CLJ3 bacteria were pelleted at 3000 r.p.m. for
5min and suspended in Hanks balanced salt solution
(HBSS; Gibco) with 0.1% gelatin, adjusted to 108 c.f.u. ml–1.
Bacteria (106) were incubated in the presence of 10%
human serum in a final volume of 3ml for 15min or 30min
at 37

C under gentle agitation. A negative control with
heat-inactivated serum (56

C for 30min) was included.
Numbers of c.f.u. were determined at 0, 15 and 30min by
serial-dilution and spreading on LB plates. Statistical signifi-
cance was determined using a t-test.
Infections of Galleria mellonella larvae
Calibrated larvae of the wax moth Galleria mellonella were
purchased from Sud-Est Appats (http://www.sudestappats.
fr). Healthy, uniformly white larvae measuring around 3 cm
were selected for infection. The bacteria were grown to an
OD600 of 1 and diluted in PBS to approximately 10
3
bacteria ml–1. Insulin cartridges were sterilized before filling
with bacterial solutions. Larvae were injected with 10 µl of
bacterial suspensions using an insulin pen. The precise
number of bacteria transferred in injections was determined
by spotting 10 µl aliquots with the pen five times onto agar
plates, and counting c.f.u. after growth at 37

C for 16 h.
Infected larvae were placed in Petri dishes and maintained
at 37

C. Dead larvae were counted over the period indi-
cated. Twenty larvae were used per condition, and the
experiment was performed twice.
RT-qPCR
To quantify selected transcripts, total RNA from 2.0ml cul-
tures (OD600 of 1.0) was extracted with the TRIzol Plus
RNA Purification Kit (Invitrogen) and treated with DNase I
(Amplification Grade; Invitrogen). Real-
time quantitative PCR (RT-qPCR) was performed as
described [38] with minor modifications (see Supplemen-
tary Materials and Methods). Primer sequences were
designed using Primer3Plus (http://www.bioinformatics.nl/
cgi-bin/primer3plus/primer3plus.cgi/) and are listed in
Table S2. Transcript quantifications are shown with SEM.
Statistical analyses
Statistical analyses were performed with ‘T-Test Calculator
for 2 Independent Means’ (https://www.socscistatistics.
Sentausa et al., Microbial Genomics 2019;5
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com/tests/studentttest), or a log-rank test. The threshold for
statistical significance was set at P<0.05.
RESULTS
Analysis of the CLJ1 genome and its regions of
genomic plasticity
CLJ1, an antibiotic-sensitive P. aeruginosa strain, was iso-
lated from a patient with necrotizing haemorrhagic pneu-
monia. Twelve days after initiating antibiotic therapy, the
patient’s condition worsened and a multidrug-resistant
clonal variant, CLJ3, was isolated [16]. CLJ1 shares the main
genomic features with the first fully sequenced antibiotic-
resistant P. aeruginosa taxonomic outlier, PA7 [16, 17]. In
particular, CLJ1 lacks the entire locus encoding the T3SS
machinery and the genes encoding all known T3SS effec-
tors; however, it carries the determinant for the two-partner
secretion pore-forming toxin, Exolysin. To initiate genome-
wide studies into the mechanisms conferring the specific
CLJ1 phenotypes, we sequenced the genome of this strain
and compared it to PA7. As expected, most core genes were
shared by the two strains (Figs 1 and S1). However, differ-
ences in the content and distribution of several variable
regions, or ‘regions of genomic plasticity (RGPs)’ as defined
by Mathee et al. [39], were detected. Thus, the CLJ1 genome
Fig. 1. Comparison of the CLJ1 and CLJ3 genomes, transcriptomes and proteomes. The overview of the two genomes, compared to
the PA7 strain reference genome, is shown on the left. The image on the right is an enlarged genomic segment at the hcn locus pre-
senting a more detailed description of the data. The three genome rings in the figure represent the pangenomes for the different
strains. Grey blocks in the PA7 ring indicate that the homologue of the CLJ1 (and CLJ3) gene in that position exists elsewhere in the
PA7 genome. Genes were ordered based on the ordering of genes in the PA7 genome, remaining genes were ordered according to
their positions in the CLJ1 contig, or when not present in either PA7 or CLJ1, the ordering of genes in CLJ3 contigs. The red bars on
charts indicate genes or proteins that were more abundantly expressed in CLJ1, whereas the green bars indicate higher expression
levels in CLJ3; darker tones indicate statistically significant differences in expression levels between the two strains (false discovery
rate<0.05). The labels on the outermost ring highlight genes that were differentially expressed in both RNA sequencing (RNA-Seq) and
at least one of the proteomics datasets. The protein subcellular localization (outermost ring) was coloured according to the coding
used in the Pseudomonas Genome Database [30]. CLJ-ISL3 insertions are indicated by red, green and blue triangles, depending on
whether they were present in CLJ1, CLJ3 or both strains, respectively.
Sentausa et al., Microbial Genomics 2019;5
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contained 15 regions that are absent from the PA7 genome,
and lacked 26 PA7 regions, including some outside recog-
nizable RGPs (Table S4). The differences between PA7 and
CLJ1 are presented in Tables S3 and S4. All CLJ1 regions
absent from PA7 (CLJ-SR), except CLJ-SR14, were detected
in other P. aeruginosa strains, some of which are phyloge-
netically unrelated to the PA7 strain. Strikingly, CLJ-SR14
carries 55 genes, including many that are predicted to
encode proteins involved in metabolism and resistance to
heavy metals (Table S5), suggesting that the strain is of envi-
ronmental origin. Moreover, the so-called Dit island previ-
ously found in a CF isolate of P. aeruginosa [39] was found
inserted into the 5¢ region of RGP27 at a tRNAGly. The
determinants encoded in this island provide the bacteria
with the ability to degrade aromatic diterpenes – tricyclic
resin acids produced by wounded trees – and to use them as
sole carbon and energy source [40]. The Dit island is
uncommon in P. aeruginosa strains, but is frequently found
in a range of soil bacteria such as Burkholderia xenovorans,
P. fluorescens and Pseudomonas mendocina. Identification
of this island further supports an environmental origin of
the CLJ1 strain. Interestingly, most of the genes within
RGP7 (pKLC102-like island) were missing from CLJ1
(Table S4).
Four gene clusters have been defined as replacement islands
in P. aeruginosa; they carry horizontally acquired material
and sequences diverge significantly between strains [41, 42].
These gene clusters encode proteins involved in the biosyn-
thesis or post-translational modification of
lipopolysaccharide (LPS) O antigen, pyoverdine, pili and
flagella. Modifications to three of these clusters can produce
the CLJ1-specific phenotype. The CLJ replacement island in
RGP60 (harbouring pilin and pilin-modification genes) car-
ries a group I pilin allele. In contrast, PA7 contains a group
IV allele [43]. Within RGP9, CLJ1 encodes a b-type flagellin
as the principal component of its flagellum, while PA7 has
an a-type flagellin [17]. RGP9, containing the flagellin gly-
cosylation genes, and the replacement island in RGP31,
bearing the O-specific antigen (OSA) biosynthesis gene
cluster, were further modified in CLJ strains (see below).
Among other potential virulence-associated genes, CLJ1
lacks one of the three copies of the type-6 secretion system
loci (PSPA7_2884–2902) encoding a machine to inject tox-
ins with activity in both prokaryotic and eukaryotic cells
[44]. The plcH and plcR genes, coding for the haemolytic
phospholipase C precursor and its accessory protein, respec-
tively, were also absent from the CLJ1 genome. Although
the cupA fimbrial gene cluster (CLJ1_2899–2903;
PSPA7_3019–3023) was present in RGP23, the entire
cupE1-6 operon (PSPA7_5297–5302), which encodes cell
surface fimbriae required to maintain a biofilm structure
[45], was missing.
Evidence of mobile genetic elements in key
pathogenic regions
The CLJ3 isolate was sampled from the same patient after a
series of aggressive antibiotic treatments and displayed
different cytotoxicity and antibiotic-sensitivity profiles com-
pared to CLJ1 [16]. The genomes of the two strains were
almost identical, with a reciprocal best-hit average nucleo-
tide identity [46] estimated at 99.97%, and >600 SNPs
between them (Fig. 1). When analysing the genomes of
CLJ1 and CLJ3, the most striking feature was the presence
of multiple copies of a 2985 bp fragment corresponding to a
mobile genetic element, absent from the reference PA7
genome. At the nucleotide level, the whole sequence of this
element was 99% identical to ISPst2 from P. stutzeri,
ISpu12 from P. putida and IS1396 from Serratia marcescens,
found in the ISfinder database [47] (Table S6). Further
examination of publicly available genome sequences (NCBI
release February 2019) by BLASTN searching revealed the
fragment to be 100% identical to a part of the pU12A_D
plasmid present in the Escherichia coli ST131 urinary tract
isolate (accession number: PRJNA516746). The complete
sequence was also detected in a few other bacterial strains,
including a multi-drug-resistant Acinetobacter baumannii
isolate recovered from bronchoalveolar lavage fluid [48].
The element is an isoform of ISPst2 and belongs to the ISL3
family, and we therefore named it CLJ-ISL3. In addition to
coding for a transposase, CLJ-ISL3 encodes a putative
seven-transmembrane domain inner-membrane protein
(344 aa, 36 kDa) from the permease superfamily cl17795
(with the conserved domain COG0701 [49]) and a putative
transcriptional metalloregulator from the ArsR family
(Fig. 2a). The element is flanked by a pair of 24 bp imperfect
inverted repeat sequences, GGGTATCCG-
GAATTTCTGGTTGAT (left inverted repeat, IRL) and
GGGTATACGGATTTAATGGTTGAT (right inverted
repeat, IRR) (Fig. 2a).
Six and 40 copies of CLJ-ISL3 were present in the genomes
of CLJ1 and CLJ3, respectively. The six insertions in the
CLJ1 genome were revealed by BLAST mining of the assem-
bled contigs. In the CLJ3 genome, most of the ISs were pre-
dicted using a combination of bioinformatics tools, analysis
of genome synteny and detection of inverted sequences
(Materials and Methods). In agreement with the clonal ori-
gin of the strains, all but one of the CLJ-ISL3 in CLJ1 were
found in the same location in the CLJ3 genome (Fig. 1,
Table S7). MS-based quantitative proteomic analyses
revealed a strong increase in expression of the transposase
protein in CLJ3 compared to CLJ1, which might be the
result of the considerably higher number of ISs within its
genome (Table S8). As mobile genetic elements contribute
significantly to phenotypic modifications by altering gene
expression or by inactivating genes [50, 51], we examined
how these insertions affected overall gene expression and
specific phenotypes. To do so, we compared CLJ1 and CLJ3
transcriptomes and proteomes using RNA-Seq and MS-
based quantitative proteomics, respectively. The proteomes
for three different bacterial fractions (whole bacteria, total
membranes and secretomes) were analysed. Stringent statis-
tical analyses of extracted data revealed 75 differentially
expressed elements between CLJ1 and CLJ3, at both mRNA
and protein levels (Fig. 1, Tables S8, S9 and S10). Among
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these elements, 27 (35%) were phage-related, while 32
(42%) were predicted to be localized in bacterial mem-
branes, the periplasm or secreted.
Contribution of CLJ-ISL3 to antibiotic resistance in
the CLJ3 strain
The CLJ1 and CLJ3 strains were recently isolated from a
patient treated unsuccessfully with high doses of various
antibiotics. CLJ1, isolated before the beginning of the antibi-
otic therapy, was sensitive to the antibiotics tested, whereas
CLJ3 displayed resistance to most of the antibiotics admin-
istered to the patient [16]. To gain insights into the mecha-
nisms of antibiotic resistance developed by CLJ3, we
examined the genomic data for gene modifications that
could explain the switch in phenotypes. Several genes
encoding proteins potentially conferring antibiotic resis-
tance were observed to be modified by ISs.
As the patient was given several antibiotics from the b-lac-
tam family (ticarcillin, carbapenem, cephalosporin, etc.) and
the CLJ3 isolate developed resistance to all of them, we
examined the status of the two major determinants of
intrinsic resistance to this group of antibiotics, the outer-
membrane porin OprD (CLJ1_4366) and the
chromosomally encoded AmpC b-lactamase (CLJ1_0728).
The oprD gene was found to be interrupted by the CLJ-ISL3
insertion (Fig. 2b), resulting in absence of the protein
(Table S8). Loss-of-function mutations or deletions in oprD
make the cell envelope impermeable to these antibiotics and
have been repeatedly reported in isolates from patients
undergoing treatment with imipenem or meropenem [52–
Fig. 2. Insertions of CLJ-ISL3 into genes encoding determinants of antibiotic susceptibility. (a) Representation of the 2985 bp CLJ-ISL3,
encompassing three genes and with inverted repeats at its extremities. (b) Representation of disruption of oprD in CLJ3 by CLJ-
ISL3. (c) Location of CLJ-ISL3 in ampD in CLJ3. (d) RT-qPCR analysis of the relative expression of ampDH3 and mipA in CLJ1 and CLJ3
strains. Error bars correspond to SEM The results of a t-test are indicated by asterisks when the difference between the two strains
was statistically significant (*P<0.05 or ***P<0.001). (e) Gene organization of the region present in PA7 and CLJ1 but absent from CLJ3.
CLJ-ISL3 was found in puuP in CLJ1, whereas both puuP and mexX were disrupted in CLJ3, with the connecting sequence replaced by
CLJ-ISL3 (see main text).
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55]. In addition, CLJ-ISL3 was detected in the 5¢ portion of
the ampD gene (Fig. 2c), encoding the recycling amidase
responsible for the production of muropeptide regulators of
ampC expression [56, 57]. Consequently, although RNA-
Seq data indicated no difference in ampC expression, CLJ3
proteomes contained significantly greater amounts of the
AmpC protein than CLJ1 extracts (Table S8).
Two additional periplasmic proteins involved in peptidogly-
can recycling and biosynthesis, the AmpDH3 amidase
(CLJ1_5671) [58] and the lytic transglycosylase MltA-inter-
acting protein MipA (CLJ1_3357) [59], were also over-rep-
resented in the CLJ3 proteome. In these cases, RT-qPCR
data indicated that the corresponding genes were also over-
expressed (Fig. 2d, Table S9). Overproduction of these pro-
teins in a clinical strain suggests a role in adaptation of the
strain to the host through modulation of peptidoglycan syn-
thesis. However, we were unable to find a link between
upregulation of those two genes and CLJ-ISL3 insertion.
The molecular mechanisms involved in the increased
expression observed and the relevance of their overexpres-
sion to bacterial persistence in the host therefore remain to
be determined.
All P. aeruginosa strains carry genes for multiple efflux
pumps. The CLJ1/PA7 clade possesses the locus encoding
the MexXY-OprA efflux pump, which can transport multi-
ple antibiotics including fluoroquinolones, aminoglycosides
and certain cephalosporins (reviewed by Li and colleagues
[60]). However, when compared to CLJ1, an approximately
20 kb deletion in the CLJ3 genome (resulting in loss of 22
genes corresponding to PSPA7_3247–3268) was detected,
corresponding to elimination of the entire transcriptional
repressor mexZ gene and truncation of mexX (Fig. 2e). The
deleted region was replaced by a copy of CLJ-ISL3 that is
bordered by truncated puuP and mexX sequences. One
plausible explanation for the genomic arrangement
observed in this region in CLJ3 is that the strain was derived
from an as-yet unidentified clonal strain that had another
copy of CLJ-ISL3 in mexX. Recombination between these
two IS elements would produce the 20 kb deletion, simulta-
neously eliminating the repressor and a portion of the mexX
genes, rendering this efflux pump non-functional. To inves-
tigate this hypothesis, we analysed the DR (direct repeat)
sequences flanking the CLJ-ISL3 sequences in both CLJ1
and CLJ3 genomes. DRs are short sequences generated dur-
ing the process of IS insertion, and their analysis can pro-
vide evidence of homologous recombination between two IS
elements. CLJ-ISL3 inserted in the CLJ1 puuP gene was
flanked by the 8-bp-long ‘TTCTTTTT’ sequence, corre-
sponding to the classical DR length for ISL3. In agreement
with our hypothesis, a hybrid element was found in CLJ3, as
the same DR sequence was found to flank one side of the IS
(in the puuP truncated gene), whereas the sequence
’AATTTTTC’ ofmexX was found on the other side. Trunca-
tion of the puuP gene, encoding putrescine importer/perme-
ase, indicates that the CLJ-ISL3 sequence affects transport
of polyamines, which play multiple roles in pathogen
biology, including conferring resistance to some antibacte-
rial agents [61].
Modifications to the OSA cluster due to CLJ-ISL3
insertions
OSA is a component of LPS and an integral component of
the cell envelope of P. aeruginosa. The OSA biosynthetic
gene cluster in CLJ, RGP31, is similar in content to that of
PA7, and both PA7 and CLJ1 belong to serotype O12 [22].
However, insertion of two different ISs affects the gene con-
tent and expression levels of the proteins encoded (Fig. 3a).
In CLJ1, the CLJ-ISL3 element was detected within the gene
encoding NAD-dependent epimerase/dehydratase
(CLJ1_1762 corresponding to PSPA7_1970), whereas in
CLJ3 two copies were present, one disrupting wbjL and the
second located in the intergenic region between CLJ3_1919
and CLJ3_1920 (PSPA7_1972). In addition, in CLJ3, two
copies of another IS, sharing 75% nucleotide identity with
ISCARN15 from the IS66 family, were detected within the
wbjB gene (CLJ1_1771; CLJ3_1930), and downstream of
wbjM (CLJ1_1778; CLJ3_1936). By performing bioinfor-
matic searches for IS extremities in CLJ1 and CLJ3 contigs,
this IS, which we named CLJ-IS66, was found to be present
in a single location in CLJ1, within the CLJ-SR12 region
(CLJ_4873-CLJ_4876). An identical insertion was found in
CLJ3. CLJ-IS66 within the OSA locus negatively affects
expression of the corresponding genes, or stability of the
mRNA produced, as higher levels of both mRNA and pro-
tein were detected in CLJ1 compared to CLJ3 (Tables S8
and S9).
Interestingly, the deletion at the mexX-puuP locus in CLJ3
described above also encompasses the galU gene
(CLJ1_3121, Fig. 2e), which encodes UDP glucose pyro-
phosphorylase [62]. This enzyme adds sugar moieties onto
the inner core on lipid A, serving as an anchor for the full-
length LPS. In the absence of galU, LPS is truncated and a
rough LPS is produced, making bacteria more susceptible to
serum-mediated killing and reducing their in vivo virulence
[63]. The CLJ3 strain was indeed more sensitive to serum
than the CLJ1 strain (Fig. 3b). The in vivo mechanism lead-
ing to selection of a serum-sensitive phenotype is unclear.
Modification to LPS structures in P. aeruginosa strains
chronically infecting CF patients is considered an adapta-
tion mechanism to a more ‘persistent’ lifestyle, by making
the LPS molecule less inflammatory [63]. Thus, multiple
mechanisms contributed to the final LPS structure in CLJ
clones. Those events could have provided strains with
numerous advantages during the infection process, such as
resistance to antimicrobials or altered recognition by the
immune system.
ISs determine the repertoire of surface appendices
Inspection of CLJ1 and CLJ3 genome sequences showed
that CLJ-ISL3 has strongly affected the flagellar biosynthetic
locus in both strains. The CLJ3 genome revealed an organi-
zation and gene content of the flagellar locus similar to that
found in PAO1, which synthesizes a b-type flagellum [64],
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but with two copies of CLJ-ISL3 (Fig. 4a). The first IS inter-
rupts flgL (CLJ1_4222), encoding the flagellar hook-associ-
ated protein through which the flagellum tethers to the cell
envelope, whereas the second IS element is in fgtA
(CLJ1_4219), which codes for the flagellin glycosyl transfer-
ase. These two ISs seem to have recombined in CLJ1, creat-
ing a deletion between the truncated fgtA and flgL genes
(Fig. 4a). In agreement, the DRs flanking the two sides of
the CLJ-ISL3 in CLJ1 are different and correspond to that
found in CLJ3 in the IS integrated within fgtA
(‘ATTTTCCA’) and flgL (‘CGAAAATA’). This recombina-
tion between two ISs suggests that CLJ1 is not the direct
ancestor of CLJ3, but that the two strains evolved from a
common ancestor. The absence of a flagellum is in agree-
ment with the non-motile phenotype of the strain observed
during eukaryotic cell infection and on soft agar [22]. Bacte-
rial flagella are also known to modulate the immune
response during the response to infection, through binding
of the major flagellar subunit, flagellin, to TLR5, which trig-
gers TLR-dependent signalling and activates expression of
pro-inflammatory cytokines [65]. The absence of assembled
flagella in the isolates explains why pro-inflammatory
cytokine IL-1b and tumour necrosis factor were undetect-
able in bronchoalveolar lavages from CLJ1-infected mice
[23, 25].
As CLJ1 also lacks twitching motility [22], we examined the
genomic data for possible mutations in genes encoding type
IV pili (T4P) and found an insertion of CLJ-ISL3 within the
5¢ part of the pilM gene in both the CLJ1 and the CLJ3
genomes (Fig. 4b). This gene encodes a cytoplasmic actin-
like protein, and is the first gene in the pilMNOPQ operon,
which is reported to be essential for both T4P biogenesis
and twitching motility [66]. Expression of the entire operon
appears to be affected, as no proteins were detected by
proteomic analysis, unlike several other Pil proteins
encoded by other operons (Table S8). This effect is probably
due to the polar effect of the IS element on the downstream
genes. This finding was intriguing as the action of Exolysin,
responsible for CLJ1 cytotoxicity, relies heavily on T4P in
another exlA+ strain, IHMA87 [67]. Therefore, we exam-
ined CLJ1 proteomes for the presence of other putative
adhesive molecules that may substitute for the T4P function
during host cell invasion. Based on proteomic datasets, the
CLJ1 strain synthesizes components of five two-partner
Fig. 3. ISs within OSA loci and how they affect serum sensitivity. (a) Comparison of the OSA region in PA7 and CLJ strains. CLJ-ISL3
was found in one location in CLJ1 and at two sites in CLJ3, whereas two copies of CLJ-IS66 were present in CLJ3. Correspondence
between non-annotated genes is shown by connecting lines. (b) Kinetics of serum killing of CLJ1 and CLJ3 strains. Bacteria were incu-
bated with human sera for the time indicated, before dilution and spotting on agar plates. Numbers of c.f.u. were counted after incuba-
tion at 37 C for 16 h. Statistical significance was determined using a t-test. ***P<0.001.
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secretion (TPS) systems, the predicted secreted
components, some of which are annotated as haemolysins/
haemagglutinins, including Exolysin (CLJ1_4479). As
expected, Exolysin (ExlA) was found to be more abundant
in the secretome produced by CLJ1 than in the secretome
from CLJ3 (log2FC  1.7, P=8.24E-02) (Table S8). CdrA and
CdrB (CLJ1_4999 and CLJ1_5000) were significantly over-
represented in the CLJ3 strain according to proteomics and
RNA-Seq analyses (Tables S8 and S9). In the PAO1 strain,
the adhesin CdrA is regulated by the secondary messenger
c-di-GMP, and its expression increases in biofilm-growing
conditions [68]. In the strains studied here, we assessed the
cellular levels of c-di-GMP using a reporter based on the c-
di-GMP-responsive cdrA promoter transcriptionally fused
to a gene encoding unstable GFP [36]. The pcdrA-gfp
(ASV)C monitoring plasmid clearly revealed higher levels of
the second messenger in CLJ3 during growth (Fig. 4c), sug-
gesting that CLJ3 may have adapted to host conditions by
switching to the biofilm lifestyle. Another TpsA protein
detected in CLJ secretomes is CLJ1_4560, an HMW-like
adhesin named PdtA in the PAO1 strain. PdtA plays a role
in P. aeruginosa virulence, as demonstrated in the Caeno-
rhabditis elegans model of infection [69]. The production of
five TPSs, including the protease LepA (CLJ1_4911) [70]
and at least one contact-dependent inhibition protein Cdi
(CLJ1_2745) [71, 72], in CLJ strains (Table S8) indicates
that this family of proteins may play an important role dur-
ing colonization and infection, but their respective contribu-
tions to adhesion, cytotoxicity or inter-bacterial competition
during the infectious process will need to be investigated.
Other putative virulence factors, phages and
metabolism
RNA-Seq results, supported by proteomics data, showed
increased expression of the enzymes HcnB (CLJ1_2955)
and HcnC (CLJ1_2954) in the CLJ1 strain (Table S10).
Fig. 4. Modifications to components associated with surface appendages. (a) Gene organization of the flgL region in PAO1 and the
CLJ1 strain. Two CLJ-ISL3, interrupting fgtA and flgL, were found in the CLJ3 genome that probably recombined in CLJ1, leaving only a
single copy of the IS. (b) Representation of the pilMNOPQ operon. CLJ-ISL3 was inserted into the pilM gene in both CLJ1 and CLJ3. (c)
Synthesis of the adhesin CdrA is linked to high intracellular c-di-GMP levels. The c-di-GMP levels in CLJ1 and CLJ3 strains were moni-
tored using the pcdrA-gfp(ASV)c plasmid. Fluorescence was measured every 15min over 6 h of growth. Error bars indicate SD.
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Inspection of the hcn operon revealed that the CLJ-ISL3 ele-
ment was inserted into the 5¢ part of the hcnB gene in the
CLJ3 genome (Fig. 5a), which explains the lack of expres-
sion measured by RT-qPCR (Fig. 5b). The hcn genes encode
the subunits of hydrogen cyanide (HCN) synthase, which
produce a toxic secondary metabolite [73]. The HCN pro-
duced by the strains was detected using a standard method
(see Material and Methods). In agreement with proteomics
data, CLJ1 produced HCN in higher quantities than CLJ3
(Fig. 5b, [22]). Many P. aeruginosa isolates from individuals
with CF produce high levels of HCN [74], and the molecule
has even been detected in the sputum of P. aeruginosa-
infected CF and bronchiectasis patients [75, 76]. HCN also
plays a regulatory role, inducing and repressing the expres-
sion of other genes [77], including the PA4129-PA4134 gene
cluster in PAO1. This seven-gene cluster (CLJ1_0701-
CLJ1_0702, CLJ1_0704-CLJ1_0708) is expressed at higher
levels in CLJ1 compared to CLJ3 (Fig. 1, Tables S8 and S9).
These results were confirmed for ccoG2 and ccoN4 by RT-
qPCR (Fig. 5c). ccoG2 codes for a cytochrome c oxidase
accessory protein and ccoN4 for a cytochrome c oxidase
subunit, both products being involved in aerobic respira-
tion. The ccoN4 gene belongs to the ccoN4Q4 operon, one of
the two ccoNQ orphan gene clusters present in the P. aerugi-
nosa genome. Its upregulation in the cyanogenic CLJ1 is in
agreement with a study showing that, although P. aerugi-
nosa encodes a cyanide-insensitive oxidase CIO, isoforms of
cbb3-type cytochrome c oxidase containing the CcoN4 sub-
unit were produced in response to cyanide, exhibiting
higher tolerance towards this poisonous molecule in low-
oxygen conditions [78]. Among the other genes in the clus-
ter are found a putative sulfite reductase-encoding gene
(CLJ1_0707) and a gene (CLJ1_0708) coding for an oxidore-
ductase probably involved in sulfite reduction; however,
their exact role is unknown.
Examining the data for differential expression of putative
virulence determinants indicated that CLJ3 overproduces
Lipotoxin F (LptF, CLJ1_1186), an outer-membrane protein
contributing to adhesion to epithelial A549 cells which is
known to activate the host inflammatory response [79]. The
lptF gene is located in a putative operon together with a
gene encoding a hypothetical protein predicted to be a lipo-
protein located in the periplasm (CLJ1_1187). Proteomics
analysis revealed this hypothetical protein to be upregulated
in CLJ3 (Table S8). As lptF upregulation was not detected
by initial RNA-Seq analysis, we performed RT-qPCR assays.
Significant overexpression of both lptF and CLJ1_1187/
CLJ3_1413 was detected in CLJ3 (Fig. 5c), suggesting that
Lipotoxin F together with CLJ1_1187 contributed to bacte-
rial adaptation to in-human environments, in line with
increased lptF expression in CF isolates [80].
Finally, prophages play important roles in P. aeruginosa
physiology, adaptation and virulence [41, 81, 82]. In the CLJ
genomes, at least eight regions related to phages were identi-
fied (Table S11), five of which differ or are absent from the
PA7 genome (Table S3). Transcriptomic and proteomic
approaches revealed 27 phage-related proteins from
CLJ1_0539–0556 in RGP3 and CLJ1_4296–4314, including
CLJ-SR11, to be significantly more abundant in CLJ3 com-
pared to CLJ1 extracts (Tables S8–S10). Interestingly, both
CLJ strains lacked the genes encoding bacteriocins, in par-
ticular pyocins S2, S4, and S5. Nevertheless, a homologue of
PrtN (CLJ1_0535), an activator of pyocin biosynthetic genes
[83], was expressed at higher levels in CLJ3 than in CLJ1.
Indeed, the prtN gene is located in a region encoding phage-
related proteins, all of which are overexpressed in CLJ3
(Fig. 1 and Table S10). The genes for AlpR (CLJ1_4295,
CLJ3_4269) and AlpA (CLJ1_4296, CLJ3_4268), transcrip-
tional regulators of a programmed cell death pathway in
PAO1 [84], were also identified in both CLJ genomes.
Finally, alpA and all the genes in the alpBCDE lysis cassette
were highly expressed in CLJ3 (Fig. 1 and Table S10). The
alp genes are present in a variable, phage-related region that
differs in gene composition from PAO1 and PA7 strains,
but is identical to that found in three recently sequenced
exlA+ isolates: AR441 (GenBank: CP029093.1), AR_0356
(GenBank: CP027169.1) and CR1 (GenBank: CP020560.1).
CLJ-ISL3 inactivates the imu operon encoding
translesion synthesis machinery
Another location of the CLJ-ISL3 element in the CLJ1 and
CLJ3 genomes was within the imu operon, also known as
the mutagenesis cassette (Fig. 5d). The imu operon encodes
the ImuC polymerase (formerly DnaE2) and other compo-
nents of translesion synthesis (TLS), which can bypass
lesions caused by DNA damage. The ImuC polymerase in
Pseudomonas contributes to tolerance to DNA alkylation
agents [85], and inactivation of the operon could limit the
accumulation of mutations. Interestingly, P. aeruginosa iso-
lates from patients with CF frequently display a hyper-
mutator phenotype, primarily linked to inactivation of
mutS. This phenotype has previously been suggested to be
advantageous for bacterial adaptation to the niche in CF
lungs [86]. The mutS gene was identical and intact in CLJ1
and CLJ3, and the predicted proteins differed from the
MutS in PA7 by a single amino acid at position 593 (threo-
nine in PA7, serine in CLJ1/CLJ3). Consequently, the physi-
ological impact of inactivation of the TLS system is unclear.
Two additional DNA-repair proteins, RecN (CLJ1_5150)
and RecA (CLJ1_1263), were over-represented in CLJ3 at
both the transcriptome and the proteome levels (Table S10),
suggesting an interplay between different mechanisms to
defend against uncontrolled mutational rates induced by a
hostile environment. More than 600 SNPs were found
between CLJ1 and CLJ3, a rate about six times higher than
that recorded for sequential isolates in the same CF patients
over 8.8 years in one study [10] and almost ten times higher
than the mutations reported in a matched isolate pair, col-
lected from a single patient with a 7.5-year interval in
another study [12]. However, yet another study indicated
that some strains isolated from non-CF patients could have
between 176 and 736 SNPs [9]. Although we could not pre-
cisely account for the role of the SNPs detected, they may
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Fig. 5. Expression of virulence factors and pathogenicity. (a) The hcn operon in CLJ1 and insertion of CLJ-ISL3 into the hcnB gene in
CLJ3. (b) Relative expression of hcnB measured by RT-qPCR and HCN production in the strains indicated. Statistical significance was
determined using a t-test. ***P<0.001. HCN production was detected by placing a paper impregnated with a reaction mixture containing
Cu2+ ions above agar plates seeded with bacteria. A white-to-blue colour transition indicates the presence of HCN in the gas phase. (c)
RT-qPCR analysis of the relative expression of ccoG2, ccoN4, lptF and CLJ1_1187 in CLJ1 and CLJ3 strains. Bars, SEM. Statistical signifi-
cance was determined using a t-test. **P<0.01 and ***P<0.001. (d) Insertion of CLJ-ISL3 into the imuABC operon. (e) Survival of Galleria
following injection of different strains. Twenty larvae were infected with 5–10 bacteria (estimated from c.f.u. counts) and their survival
was monitored over the indicated period. PBS was injected as a vehicle-control. ***P<0.001.
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contribute to differences in gene expression between the
two isolates that could not be directly attributed to ISs.
The two CLJ clones show different pathogenic
potential in G. mellonella
To assess the overall virulence of the two strains in a whole
organism, we used the wax moth (Galleria) infection model,
and monitored the survival of infected larvae following
inoculation with the different strains. Under the same infec-
tion conditions, the CLJ1 strain was found to be more viru-
lent than the PA7 strain, and CLJ3 was unable to kill
Galleria larvae (Fig. 5e). This result indicates that CLJ3, in
the process of gaining resistance to antimicrobials, lost its
virulence potential, a finding that agrees with our previous
observation that CLJ3 is sensitive to serum (Fig. 3b) and less
cytotoxic due to loss of its ability to secrete Exolysin [16].
More than 40 CLJ-ISL3 ISs were detected in the CLJ3
genome, some within or upstream of genes encoding hypo-
thetical proteins or putative regulators (Table S7), and some
of which may have influenced fitness of the CLJ3 strain in
the Galleria model of infection. Thus, we found that ISs
contributed significantly to the pathogenicity of the CLJ1
strain and to the multi-drug resistance of CLJ3. As the two
isolates may have coexisted in the patient’s lungs, we can
conclude that ISs determined the overall success of the CLJ
lineage in establishing lethal infection.
DISCUSSION
P. aeruginosa strains from the group of taxonomic outliers
are abundant in humid environments [18, 19, 87, 88] and,
based on a previous study, are considered to be innocuous
[89]. Here, we present the results of a multiomics approach
applied to two recent clinical isolates, CLJ1 and CLJ3, mem-
bers of the same group of taxonomic outliers. The results
provided insights into genome-wide modifications that pro-
vided these bacteria with the tools to successfully colonize
and disseminate within the human host. We found the
genomes of both strains to be highly dynamic and to evolve
within the patient due to high numbers of ISs. General path-
ogenic and survival traits, e.g. motility, adhesion and resis-
tance to antimicrobials, were modulated by the CLJ-ISL3
element. The later isolate, CLJ3, had acquired resistance
toward antibiotics with which the patient was treated during
hospitalization, and some ISs directly affected components
involved in resistance. Compared to the early colonizer
CLJ1, the CLJ3 strain also displayed higher intracellular lev-
els of c-di-GMP, higher expression of the biofilm-associated
adhesion protein CdrA, and had lost part of its LPS due to
deletion of the galU gene. All these features promoted adap-
tation to a lifestyle associated with chronic infection. More-
over, by bioinformatics screening we
identified 36 additional IS elements in the CLJ3 genome,
and these probably contributed to other phenotypic changes
which were not assessed in this study. In addition to previ-
ously known virulence determinants, several of the genes
that were differentially expressed here were annotated as
‘hypothetical’ by RAST automated annotation technology.
Their contribution to P. aeruginosa’s adaptation to life
within a human host should now be further explored.
Although the precise origin of the CLJ-ISL3 identified in the
CLJ lineage is unknown, we speculate that it was acquired
from another bacterial species present in the environment.
Indeed, the GC content of the CLJ1-ISL3 sequence is
54.8%, whereas in the rest of the P. aeruginosa genome it is
66.6%, suggesting recent acquisition by horizontal transfer.
Initial disruption of the genes encoding flagellar compo-
nents and pili by this sequence may have allowed the CLJ
strain to evade the patient’s immune defences. By increasing
its capacity to secrete the pore-forming toxin Exolysin, the
strain acquired an additional advantage allowing it to fur-
ther damage the host epithelium and endothelial tissues to
promote its dissemination.
Previous studies have indicated that the contribution of ISs
to the adaptation of P. aeruginosa to the environment in
patients with CF is low, with limited numbers of transposi-
tion events occurring during chronic infection [90]. This
finding contrasts with reports on in vitro evolution experi-
ments with E. coli [91, 92]. A search of the Pseudomonas
database [28] with the nucleotide sequence of the CLJ1-ISL3
fragment revealed a total of 12 strains bearing 100% identi-
cal fragments. Eight of these strains were isolated at Copen-
hagen University Hospital [93], and the four others in a
Seattle-based hospital intensive care units [94]. The precise
positions of CLJ-ISL3 in those genomes and the phenotypes
produced by the disrupted gene(s) are currently unknown,
but this knowledge could provide insights into whether and
how the CLJ-ISL3 sequence contributes to the colonization
process and the adaptation of those strains to a particular
infectious niche. More recent genomic characterization of
environmental P. aeruginosa isolates from dental unit
waterlines showed that, in addition to the OSA loci, ISPa11
altered the genes for two master regulators, LasR and GacS,
supporting the idea of a potential for ecological adaptation
of P. aeruginosa through the integration of mobile elements
[95]. Thus, in addition to small nucleotide changes in path-
oadaptive genes, mobile genetic elements could drive the
emergence of phenotypic traits allowing P. aeruginosa to
adapt to the niche they encounter, and undoubtedly con-
tribute to strain-specific pathogenicity. The overall contri-
bution of ISs to the increase in the bacterial pathogenic
arsenal is quite likely to be underestimated as we currently
have limited access to closed bacterial genomes. New DNA
sequencing technologies accessing genome fragments mea-
suring tens or even hundreds of kilobases should shed light
on the overall impact of mobile elements throughout bacte-
rial evolution.
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